跳至主要内容
临床试验/DRKS00021242
DRKS00021242已完成未知

Cortico-spinal interactions underlying pain and pain modulation

niversitätsklinikum Hamburg-Eppendorf0 个研究点目标入组 92 人开始时间: 2020年4月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
92

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Male

入选标准

  • Healthy, fully competent, male gender, ages between 18 and 45 years, no use of illegal drugs, average alcohol consumption less than 15 glasses per week, cigarette consumption averages less than 20 cigarettes per day

排除标准

  • Chronic pain conditions, acute pain in the last 4 weeks, open injuries, inflammation or skin infections, any long-term medication, participation in another drug-related study in the last 2 months, severe somatic, neurological or psychiatric illness, cancer, alcohol, medication or drug addiction, other serious health problems, current severe mental or physical exertion, hypersensitivity or intolerance to remifentanil, MRI-specific exclusion criteria

研究者

发起方
niversitätsklinikum Hamburg-Eppendorf

相似试验